Cite

HARVARD Citation

    Law, C. et al. (2023). A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis. Expert review of gastroenterology & hepatology. pp. 109-117. [Online]. 
  
Back to record